Follow the 프레스티지바이오파마 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 프레스티지바이오파마 has recorded 43 insider filings. The latest transaction was reported on 9 July 2026 (Other). Among the most active insiders: 옥타바펀드리미티드. The full history is openly available.
43
Insider Decl.
0
Thresholds
·
14 ops.
Buy Volume
·
0 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Prestige Biopharma is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of innovative biologic drugs.